Hair Relaxer & Uterine Cancer Risk - Episode #55

By Tamara Thomas - Last Updated: August 1, 2023
Also available on the following streaming services
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links

On this episode, we discuss research that says drug prices don’t reflect R&D cost; transgender men and the abortion fight; hair relaxer and uterine cancer risk; and more.

Related Podcasts

Conversations with Patient Advocates - Episode #105
Interviews with Key Healthcare Opinion Leaders - Episode #104
Interviews with Key Healthcare Opinion Leaders - Episode #103
Interviews with Key Healthcare Opinion Leaders - Episode #102
FDA GRAS Loophole - Should Buyers Beware? - Episode #101
Advertisement
Advertisement
Latest News

PTSD in Older Adults: A Critical Gap in Urban Mental Health Care

July 14, 2025

Autoimmune Diseases Double Mental Health Risk, Especially for Women

July 13, 2025

Nearly 30% of Medical Students Now Pursuing DO Degrees

July 13, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    Contact Us

    eNewsletters

    Work With Us

    Advertising

    Career Center

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |